MCL1 and colorectal carcinoma: In this study, we first demonstrated that combination treatment using metformin and TRAIL synergistically inhibited proliferation of and induced apoptosis in human CRC cell lines, in addition to reducing the expression of Mcl-1, p-JAK2, and p-STAT3 (Supplementary Figure S1).